Vetoquinol SA, a veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products in Europe, the Americas, and the Asia Pacific region. It provides products in the areas of mobility, pain, and inflammation; dermatology, hygiene, and care; anti-parasite; udder health; infectious diseases; reproduction; behavior management; internal medicine; and cardiology-nephrology for cattle, sheep, pigs, poultry, and dogs. The company was founded in 1933 and is headquartered in Lure, France. Vetoquinol SA is a subsidiary of Soparfin SCA.

Vetoquinol SA

Vetoquinol is an independent, family-owned business that develops, produces, and markets veterinary pharmaceuticals and health products for animals. Self-described commitment to values and a close relationship with veterinary clients.

Metric
Company Name	Vetoquinol SA
Symbol	VETO
MSH ID	COM:VETOQUINOL
Market	STOCKS
Sector	Healthcare
Industry	Drug Manufacturers - Specialty & Generic
Country	FR
Stage
Employee Count	2.44K
Website	vetoquinol.com
LinkedIn
Founders

Metric
Market Cap	1.21B
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue	559.06M
Revenue (LTM)
Revenue (NTM)
Gross Profit	559.06M
EBITDA	559.06M
Operating Income	559.06M
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.59
Operating Profit Margin	0.58
EBITDA Margin	1
Net Profit Margin	0.11
Return on Equity	0.13
Return on Assets	0.08
Return on Capital Employed	0.53

COM:VETOQUINOL

Vetoquinol

Last Close

79.30

25/11 09:24

Market Cap

1.14B

Beta: -

Volume Today

566

Avg: -

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	25.79
P/B Ratio	2.55
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	2.35
EV Multiple	14.81

Metric
Days Sales Outstanding
Days Payables Outstanding	89.27
Days Inventory Outstanding	173.57
Operating Cycle	236.83
Cash Conversion Cycle	144.80
Asset Turnover	0.76

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt	13.63
Operating Cash Flow/Sales	0.17
Free Cash Flow Yield	0.03

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization	0.03
Debt to Assets	0.03
Current Ratio	2.19
Quick Ratio	1.91

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue	0.00
R&D to Revenue	0.01
SG&A to Revenue	0.13